Pfizer Philippines, PCOM elevate healthcare professionals' capabilities in landmark partnership to optimize health of Filipino workforce

 

Pfizer Philippines Country Manager So-Myung Lim (Left) and PCOM President Dr. Anna Sofia Victoria Tamayo Salazar-Fajardo

 

·         The partnership allows Pfizer Philippines and the Philippine College of Occupational Medicine

(PCOM) to conceptualize, launch and implement continuing medical education programs geared

toward providing online information and learning.

 

·         Through the partnership, PCOM members are expected to gain knowledge on the basics and

current trends of relevant topics and be able to create updated educational modules for both PCOM Healthcare Providers (HCPs) and Employees of Corporations, among other benefits.

 

MANILA, PHILIPPINES – Pfizer Philippines has partnered with the PCOM in an aim to provide educational initiatives to HCPs, promote enhanced learning, and drive excellence in clinical care.

 

The landmark partnership was solidified through a memorandum of agreement (MoA) signed by Pfizer

Philippines Country Manager So-Myung Lim and PCOM President Dr. Anna Sofia Victoria Tamayo Salazar-Fajardo in a ceremony today at the Manila Hotel.

 

This milestone is a major boost to Pfizer’s goal of increasing access to quality healthcare services and

information through sustainable programs and strong collaborations with health stakeholders, especially

those in the medical community. This is also consistent with PCOM's goal of promoting enhanced learning and driving excellence in patient care among its members. Ultimately, the partnership will strengthen initiatives aimed at safeguarding and promoting workers' health, wellness, and safety.

 

"At Pfizer Philippines, we are all-in on our purpose of bringing breakthroughs that change patients’ lives

and in advancing our business principle 'Science will win'. We believe that fostering collaborations across

various stakeholders is vital in accelerating the ability of HCPs to address occupational health and safety

needs,” said Lim.

 

“The initiatives that are part of this remarkable partnership with PCOM will drive not only our healthcare

system, but also the Filipino workforce towards growth, especially as we continue to recover from the

pandemic. We are grateful for this opportunity to work with PCOM and looking forward to the milestones

that we’ll achieve together,” added Lim.

 

Under the agreement, Pfizer and PCOM will conceptualize, launch, and implement continuing medical

education programs, specifically Continuing Professional Development through the Modular Learning

System and Webinars, which are geared toward providing online information and learning.

 

The MoA also allows the organizations to coordinate an information drive regarding workforce healthcare

and protection through vaccination with various educational channels such as webinars and chapter event, including lay forum modules cascaded to employees of corporations managed by PCOM members.

 

Through the partnership, PCOM members are expected to gain knowledge on the basics and current trends of relevant topics, including vaccine-preventable diseases for employees, disposition of employees with contagious disease, and post-exposure prophylaxis for employees, among others.

 

“We at PCOM recognize that Pfizer Philippines has the capability and resources to create collaborations

and develop initiatives to advance the knowledge of healthcare professionals in relation to occupational

health and safety,” said Dr. Fajardo.

 

“PCOM and Pfizer also have a shared belief that effective collaboration can go a long way in pursuit of

continuing education for the medical community to consequently bring positive impact to the Filipino

workforce, hence contributing to the recovery of our economy in the post-pandemic era. We found a key

partner in Pfizer, and we are beyond grateful to share expertise for future initiatives,” added Dr. Fajardo.

 

 

About Pfizer: Breakthroughs That Change Patients’ Lives

 

At Pfizer, we apply science and our global resources to bring therapies to people that extend and

significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery,

development and manufacture of healthcare products, including innovative medicines and vaccines.

 

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness,

prevention, and treatment that challenge the most feared diseases of our time. Consistent with our

responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with

HCPs, government and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @PfizerNews, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.